Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyfé has demonstrated the ability to convert nutrient-rich wastewater from food processing into valuable feedstocks for biomanufacturing and clean water. The company has raised $11 million in funding to advance commercial partnerships and scale its technology demonstration. Its initial product was mycelium flour made via fermentation of upcycled sugar water but pivoted to focus on enabling the broader bioeconomy through low-cost alternative feedstocks.
No clinical results as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyfé.